多层螺旋CT鉴别胰腺腺泡细胞癌与胰腺导管腺癌的诊断效能
该回顾性研究纳入17例胰腺腺泡细胞癌(PACC)和62例胰腺导管腺癌(PDAC)患者,评估多层螺旋CT(MSCT)的鉴别诊断价值。多因素分析显示肿瘤边缘、胰管截断和胰腺实质期CT衰减值是独立预测因子,联合诊断模型AUC达0.968,敏感度94.1%、特异度88.7%。
要点
- 肿瘤边缘、胰管截断及胰腺实质期CT衰减值是鉴别PACC与PDAC的独立预测因子。
- 联合这三项特征的诊断模型AUC为0.968,敏感度94.1%、特异度88.7%。
- PACC与PDAC在肿瘤形态、边缘、胰腺萎缩、胰管截断及多期强化特征上存在显著差异。
核心结论
- 肿瘤边缘、胰管截断和胰腺实质期CT衰减值是鉴别PACC与PDAC的重要影像特征。
- 整合上述特征的联合诊断模型具有优异的诊断效能,可能有助于提高术前鉴别诊断水平。
研究设计与样本
- 回顾性分析17例经病理证实的PACC和62例PDAC患者的临床、病理及影像资料。
- 采用独立样本t检验或Mann-Whitney U检验比较定量变量,Pearson卡方检验或Fisher精确检验比较定性变量。
- 将单因素分析中有统计学意义的变量纳入多因素logistic回归分析,以确定鉴别PACC与PDAC的独立预测因子。
- 采用受试者工作特征(ROC)曲线分析评估诊断效能,计算AUC、敏感度、特异度、阳性预测值、阴性预测值和准确率。
关键影像表现/征象
- 单因素分析显示两组在肿瘤形态、边缘、胰腺萎缩、胰管截断、最大肿瘤直径、CT衰减值以及胰腺实质期、门静脉期和延迟期的强化比值上均有统计学显著差异。
- 多因素logistic回归分析确定肿瘤边缘、胰管截断和胰腺实质期CT衰减值为鉴别PACC与PDAC的独立预测因子。
诊断标准与关键数值
- 联合诊断模型(纳入肿瘤边缘、胰管截断、胰腺实质期CT衰减值)鉴别PACC与PDAC的AUC为0.968。
- 该模型敏感度为94.1%,特异度为88.7%,准确率为89.9%,阳性预测值为69.5%,阴性预测值为98.2%。
临床应用与阅片要点
- 在日常阅片中,应重点关注肿瘤边缘特征、是否出现胰管截断以及胰腺实质期CT衰减值,以辅助鉴别PACC与PDAC。
- 联合上述三项影像特征的综合诊断模型可提供高敏感度和高阴性预测值,有助于排除PDAC或提示PACC可能。
局限性
- 本研究为单中心回顾性分析,样本量有限(PACC仅17例),结论需更大规模前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the diagnostic value of multislice spiral computed tomography (MSCT) in differentiating pancreatic acinar cell carcinoma (PACC) from pancreatic ductal adenocarcinoma (PDAC).
METHODS: The clinical, pathological, and imaging data of 17 patients with pathologically confirmed PACC and 62 patients with PDAC were retrospectively analyzed. Quantitative variables were compared between groups using the independent samples t-test or the Mann-Whitney U test, as appropriate. Qualitative variables were compared using the Pearson's chi-square test or Fisher's exact test. Variables showing statistical significance in univariate analysis were entered into multivariate logistic regression analysis to identify independent predictors for distinguishing PACC from PDAC. Diagnostic performance was assessed using receiver operating characteristic curve analysis, with calculation of the area under the curve (AUC), sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.
RESULTS: Univariate analysis demonstrated significant differences between the two groups in tumor shape, margin, pancreatic atrophy, pancreatic duct transection, maximum tumor diameter, CT attenuation values, and enhancement ratios in the pancreatic parenchymal, portal venous, and delayed phases, all of which showed statistically significant differences. Multivariate logistic regression analysis identified tumor margin, pancreatic duct transection, pancreatic parenchymal phase CT attenuation value as independent predictors for distinguishing PACC from PDAC. The combined diagnostic model incorporating these variables achieved the highest diagnostic performance, with an AUC of 0.968. The model demonstrated a sensitivity of 94.1%, specificity of 88.7%, accuracy of 89.9%, positive predictive value of 69.5%, and negative predictive value of 98.2%.
CONCLUSION: Tumor margin, pancreatic duct transection, and pancreatic parenchymal phase CT attenuation value are significant imaging features for differentiating PACC from PDAC. A combined diagnostic model integrating these imaging features provides excellent diagnostic performance and may aid in improving preoperative differential diagnosis.
引用
- Yu J, Cao Y, Xia F, et al. Diagnostic performance of multislice spiral computed tomography in differentiating pancreatic acinar cell carcinoma from pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2026. PMID: 42340462. doi:10.1007/s00261-026-05617-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。